Department

Biological Sciences

Major

Biology

Research Advisor

Aronstam, Robert

Advisor's Department

Biological Sciences

Funding Source

UMR cDNA Resource Center

Abstract

Epitope tagging of G-protein coupled receptors (GPCRs) typically involves the addition of a specific antigenic amino acid sequence (e.g., hemagglutinin) to the N-terminus, a region not involved in receptor ligand binding or signal transduction functions. However, with certain GPCRs this method fails due to posttranslational cleavage of the N-terminal tag or inhibition of membrane isertion. To overcome this, we modified a cloning vector so that it would insert an artificial cleavage site at the N-terminus of the protein before the epitope. This ensures that a functional receptor will be expressed and properly inserted into the membrane. Clones of an opioid and calcitonin-like receptor (the tagged versions of which are subject to improper post-translational processing) were tagged using this new vector. The modified clones were expressed in a mammalian cell line and visualized using immunofluorescence. This method offers an efficient means to create immunologically identifiable constructs of human GPCRs.

Biography

Heather Lavezzi is a sophomore in Biological Sciences from Moberly, Missouri. Heather plays violin in the UMR Chamber Orchestra and she plans to attend medical school.

Research Category

Natural Sciences

Presentation Type

Poster Presentation

Document Type

Poster

Location

Havener Center, Carver-Turner Room

Presentation Date

11 April 2007, 1:00 pm - 3:00 pm

Share

COinS
 
Apr 11th, 1:00 PM Apr 11th, 3:00 PM

Novel Method to Express Functional Epitope-Tagged GPCRs

Havener Center, Carver-Turner Room

Epitope tagging of G-protein coupled receptors (GPCRs) typically involves the addition of a specific antigenic amino acid sequence (e.g., hemagglutinin) to the N-terminus, a region not involved in receptor ligand binding or signal transduction functions. However, with certain GPCRs this method fails due to posttranslational cleavage of the N-terminal tag or inhibition of membrane isertion. To overcome this, we modified a cloning vector so that it would insert an artificial cleavage site at the N-terminus of the protein before the epitope. This ensures that a functional receptor will be expressed and properly inserted into the membrane. Clones of an opioid and calcitonin-like receptor (the tagged versions of which are subject to improper post-translational processing) were tagged using this new vector. The modified clones were expressed in a mammalian cell line and visualized using immunofluorescence. This method offers an efficient means to create immunologically identifiable constructs of human GPCRs.